FLFS
KURA icon

Family Legacy Financial Solutions’s Kura Oncology KURA Stock Holding History

Family Legacy Financial Solutions’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$885 – 147
2025
Q3 		$885 Hold
100
– – ﹤0.01% 238
2025
Q2 		$577 Buy
+100
New +$613 ﹤0.01% 227

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Family Legacy Financial Solutions's KURA Position: Q4 2025 in Review

Family Legacy Financial Solutions sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 100 shares — an estimated $885 sold.

Family Legacy Financial Solutions first reported a position in KURA in Q2 2025 and held it in 2 quarters. The position peaked at $885 in Q3 2025. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Family Legacy Financial Solutions reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Family Legacy Financial Solutions sold 100 Kura Oncology shares in Q4 2025, an estimated $885.
  • Family Legacy Financial Solutions first reported a position in Kura Oncology in Q2 2025 and held it in 2 quarters.
  • Family Legacy Financial Solutions's Kura Oncology position peaked at $885 in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Family Legacy Financial Solutions's 13F filing for Q4 2025, filed 20 Jan 2026.